[{"id":"89444d08-623a-4c04-acb0-e40430217e81","acronym":"GLIOFET","url":"https://clinicaltrials.gov/study/NCT04001257","created_at":"2021-01-18T19:40:01.355Z","updated_at":"2024-07-02T16:36:51.197Z","phase":"","brief_title":"18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma","source_id_and_acronym":"NCT04001257 - GLIOFET","lead_sponsor":"University Hospital, Brest","biomarkers":" ATRX","pipe":" | ","alterations":" ATRX deletion • MGMT mutation","tags":["ATRX"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ATRX deletion • MGMT mutation"],"overall_status":"Completed","enrollment":" Enrollment 60","initiation":"Initiation: 06/17/2019","start_date":" 06/17/2019","primary_txt":" Primary completion: 09/17/2019","primary_completion_date":" 09/17/2019","study_txt":" Completion: 09/17/2019","study_completion_date":" 09/17/2019","last_update_posted":"2020-01-18"}]